earnings
confidence high
sentiment positive
materiality 0.80
ResMed Q4 revenue up 10% to $1.35B, EPS $2.58; dividend raised 13% to $0.60
RESMED INC
2025-FY EPS reported
$9.51
revenue$5,146,327,000
- Q4 revenue $1.35B (+10% YoY, +9% CC); GAAP EPS $2.58 (+30%), non-GAAP EPS $2.55 (+23%).
- Gross margin up 230bps to 60.8% GAAP; operating income $454.5M (+19%).
- FY2025 revenue $5.15B (+10%); GAAP EPS $9.51 (+37%).
- Dividend raised 13% to $0.60/share; payable Sept 18, record Aug 14; ex-div Aug 13.